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Endometriosis is a common chronic 




176 million women worldwide
are affected by endometriosis
Endometriosis costs 
the world economy
>$80 billion per year
Only 20% of the
general public have 
heard of endometriosis
Only 1/3 women feel their 
current pain treatment is 
effective 
40% of infertile 
women are affected 
by endometriosis
On average it takes 








There are three subtypes of endometriosis
2
GWAS analysis has identified 19 SNPs several of which are at or near genes with 
imporant roles in sex steroid signaling and function













Easy to take, generally well 
tolerated, can be stopped quickly
Advantages
Convenient and easy to 
take, not contraceptive
Convenient and easy to 
take, not contraceptive
Easy to take, generally well 
tolerated, can be stopped quickly
Can stop menstruation, 
generally well tolerated.
Blocks ovulation, evidence or 
positive impacts on pain.
Contraceptive, can increase risk 
of hypertension.
Disadvantages
Gi disturbances, evidence of 
efcacy inconclusive.
Risk of addiction.
Contraceptive, may result in 
unscheduled endometrial bleeds
Contraceptive, may result in 
unscheduled endometrial bleeds.
Mimics menopause. Hot ushes, 
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Anatomy of a lesion:
Fibrosis (F), blood vessels (red), immune cells and
nerves that connect to the CNS via dorsal root ganglia
Changes in mesothelial
cells lining the peritoneum = “soil”





 l i   i i    l  i       i  




See online version for 
legends and references
1.e1 Cell 179, December 12, 2019 © 2019 Elsevier Inc. DOI: https://doi.org/10.1016/j.cell.2019.11.033
SnapShot: Endometriosis
Andrew W. Horne and Philippa T.K. Saunders
EXPPECT Centre, The University of Edinburgh, Edinburgh, UK
Endometriosis is a chronic, estrogen-dependent, neuroinflammatory condition that is associated with pelvic pain. It affects an estimated 176 million women worldwide 
(~10% of women of reproductive age). While the socioeconomic impact of endometriosis is high (>80 billion USD, >70 billion euros per year), awareness among public and 
health care practitioners is low relative to disorders with similar prevalence and societal burden, e.g., diabetes (Horne et al., 2017).
Clinical Phenotypes, Symptoms, Comorbidities and Natural History
Endometriosis is defined by the presence of endometrial-like tissue (“lesions”) outside the uterus. Three subtypes of endometriosis are described: superficial peritoneal, 
ovarian (endometrioma cysts), and deep (infiltrating) (Johnson et al., 2017). It is estimated that 50%–60% of women with chronic pelvic pain have endometriosis, but there is 
poor correlation between pain severity and the amount, location, and subtype of endometriotic lesions, with some women being asymptomatic. Women with endometriosis 
are at higher risk of infertility; ovarian, endometrial, and breast cancers; melanoma; asthma; and autoimmune and cardiovascular disease (Kvaskoff et al., 2015). The natural 
history of the disease is uncertain. It is not known whether superficial peritoneal disease can progress to become another subtype and whether disease progression (or lack of 
treatment) can lead to worsening symptoms. Genetic, hormonal, anatomical, and immunological factors are all implicated in the formation and development of endometriotic 
lesions
Diagnosis and Clinical Management
There are no accurate non-invasive biomarkers of endometriosis. As definitive diagnosis requires surgery, there is often a long diagnostic delay after onset of symptoms 
(~7–9 years). Ovarian and deep endometriosis subtypes may be identified on imaging (e.g., ultrasound or MRI). Current treatment options for endometriosis are largely inad-
equate. Medical treatments mostly reduce circulating estrogen concentrations and, hence, may induce menopausal-like symptoms and lead to bone demineralisation. Surgical 
treatments aim to excise or ablate all visible disease, but persistence/recurrence rates of endometriosis after surgery are as high as 20% after 2 years and 40%–50% after 5 
years.
Genetics
Twin studies report the heritable component of endometriosis as ~50%. Large-scale genome-wide association studies (GWASs) have been conducted, with new insights 
gained by pooling data in meta-analyses: recent findings have identified at least 19 independent SNPs significantly associated with endometriosis, some of which appear 
associated with genes implicated in steroid hormone signaling (Sapkota et al., 2017). Cross-disease GWAS meta-analysis identified 13 distinct loci associated with both endo-
metriosis and endometrial cancer, complementing the epidemiological evidence of an association. In addition, a recent study detected somatic cancer driver mutations in cells 
in deep endometriotic lesions (Anglesio et al., 2017).
Survival of Endometrial Tissue and Establishment of Endometriosis Lesions: An Example of “Seed and Soil”?
Reflux of endometrial tissue fragments/cells and protein-rich fluid through the fallopian tubes into the pelvis during menstruation is considered the most likely explanation 
for why endometriotic lesions form within the peritoneal cavity. Studies exploring why lesions develop in some, but not all, women have detected changes in the endometrial 
tissue (the “seed”) as well as the peritoneal fluid and cells lining the cavity (the “soil”). Analyisis of eutopic endometrium from women with endometriosis has identified altered 
expression of genes implicated in the inflammation/immune response, angiogenesis, and steroid responsiveness (progesterone “resistance”) (McKinnon et al., 2018). Shed 
menstrual tissue contains high concentrations of pro-inflammatory cytokines, proteases, and immune cells, all of which may influence the peritoneal microenvironment after 
reflux. Stem/progenitor cells have been identified in the endometrium and are thought to survive and implant onto the peritoneum, contributing to lesions (Cousins et al., 2018). 
Mesothelial cells line the pelvic peritoneal cavity and cover the surface of the ovary, and changes in their function in women with endometriosis including altered morphology, 
metabolism (switch to aerobic glycolysis) (Horne et al., 2019), and production of factors that promote immune cell recruitment and angiogenesis are all thought to favor survival 
and establishment of lesions (Young et al., 2013). Physiological hormonal fluctuations in women induce cyclical episodes of cell proliferation, inflammation, injury, and repair 
within lesions that favor fibroblast to myofibroblast differentiation and fibrosis.
Mechanisms Contributing to Endometriosis-Associated Pain
The development of a new blood supply and associated nerves (neuroangiogenesis) are considered key to the establishment of endometriotic lesions and activation of 
peripheral pain pathways. Sensory C, sensory Ad, cholinergic, and adrenergic nerve fibers have all been detected in lesions. Estrogens can promote cross-talk between 
immune cells and nerves within lesions, increasing expression of nociceptive ion channels such as TRPV1 (Greaves et al., 2015). Factors that promote inflammation and nerve 
growth, such as NGF, TNFa, and IL1b, are increased in the peritoneal fluid of women with endometriosis and may exacerbate a neuroinflammatory cascade. Endometriosis-
associated chronic pelvic pain is associated with alterations in the CNS of women, including changes in the volume of regions of the brain and in brain chemistry (As-Sanie et 
al., 2012).
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